Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Extended Validation of Donor-derived Cell-free DNA in Kidney Transplant Recipients

ClinicalTrials.gov ID: NCT07805343

Public ClinicalTrials.gov record NCT07805343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multinational Study to Evaluate the Performance of Donor-derived Cell-free DNA in Detecting Kidney Allograft Rejection Across Context of Use, Populations, and Injury Phenotypes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multinational, multi-center, observational cohort study. Kidney allograft rejection is poorly detected by standard-of-care biomarkers. Although dd-cfDNA has been associated with improved rejection detection when added to standard-of-care biomarkers and clinical parameters, little is known about its performance across Banff 2022 rejection phenotypes and injury patterns, in various clinical scenarios and populations, and when measured repeatedly over time.

Study identification

NCT ID
NCT07805343
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Enrollment
5,000 participants

Conditions and interventions

Interventions

Diagnostic Test

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 15, 2024 (Actual)
Primary completion
Dec 1, 2026 (Estimated)
Completion
Dec 31, 2026 (Estimated)
Last update posted
Sep 4, 2026

2024 – 2026

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA Los Angeles California 90048 —
Department of Pediatrics, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA. Los Angeles California 90048 —
Division of Nephrology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA Los Angeles California 90095 —
Department of Nephrology, Tampa General Hospital, Tampa, FL, USA Tampa Florida 33606 —
Division of Pediatric Nephrology, Emory University School of Medicine, Atlanta, GA, USA Atlanta Georgia 30322 —
Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA St Louis Missouri 63110 —
Division of Pediatric Nephrology, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, USA St Louis Missouri 63110 —
Division of Nephrology, Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, NY, USA New York New York 10065 —
Cleveland Clinic, 2050 East 96th Street, Cleveland, OH Cleveland Ohio 44195-0001 —
Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Dallas Texas 75390-8856 —
Transplant Services, Intermountain Medical Center, Murray, UT, USA Murray Utah 84107 —
Division of Nephrology, Department of Medicine, University of Utah Health, Salt Lake City, UT, USA Salt Lake City Utah 84132 —
Division of Nephrology, Virginia Commonwealth University, Richmond, VA, USA Richmond Virginia 23219 —
Department of Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07805343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07805343 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →